Host antisecretory targets are a promising treatment option for easing the symptoms of diarrheal disease and addressing shortcomings of existing therapies. This poster presentation from the American Society of Tropical Medicine and Hygiene 2016 Annual Meeting summarizes the results of tests comparing several clinical-stage drug candidates that have the potential to treat acute secretory diarrhea.
Corporate author(s): PATH, Center for World Health and Medicine, Saint Louis University, Gateway Pharmacology Laboratories
Publication date: November 2016
455 KB PDF
Hard copies are not available.
Some digital files may be saved at low resolutions to conserve file size. Versions with higher quality may be available; see the contact information below to enquire.
This publication is part of the series ASTMH posters
Related regions: Global
- Emerging and epidemic diseases > Drug development
- Maternal and child health > Controlling diarrheal disease
For more information…
Contact: PATH Publications
Mailing address: PATH, PO Box 900922, Seattle, WA 98109 USA